These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25819481)

  • 1. Assessment of a screening protocol for type 2 diabetes in community pharmacy. The DiabNow Study.
    Fikri-Benbrahim N; Martínez-Martínez F; Saéz-Benito L; Luque BS; Corpas JP; Moullin JC; Sabater-Hernández D
    Diabetes Res Clin Pract; 2015 Jun; 108(3):e49-52. PubMed ID: 25819481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    PLoS One; 2018; 13(2):e0191316. PubMed ID: 29474501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
    Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
    BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy characteristics correlating to performance in a community pharmacy network.
    Renfro CP; Urick BY; Mansour MA; Ferreri SP
    J Am Pharm Assoc (2003); 2019; 59(2):275-279. PubMed ID: 30827530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When procedures meet practice in community pharmacies: qualitative insights from pharmacists and pharmacy support staff.
    Thomas CE; Phipps DL; Ashcroft DM
    BMJ Open; 2016 Jun; 6(6):e010851. PubMed ID: 27266770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes, costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System in Thailand: a systematic review.
    Asayut N; Sookaneknun P; Chaiyasong S; Saramunee K
    Int J Pharm Pract; 2018 Feb; 26(1):16-27. PubMed ID: 28795519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacy screening project--an evaluation of pharmacy-based screening programmes.
    Flobbe K; IJsselmuiden CB; Rheeder P; Gerber JJ; Lubbe M
    S Afr Med J; 1999 Sep; 89(9):980-6. PubMed ID: 10554636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy.
    Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Mc Namara KP
    Diabetes Res Clin Pract; 2023 Mar; 197():110566. PubMed ID: 36738834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.
    Krass I; Armour CL; Mitchell B; Brillant M; Dienaar R; Hughes J; Lau P; Peterson G; Stewart K; Taylor S; Wilkinson J
    Diabet Med; 2007 Jun; 24(6):677-83. PubMed ID: 17523968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.
    Santana CR; de Oliveira MGG; Camargo MS; Moreira PMB; de Castro PR; Aguiar EC; Mistro S
    Int J Pharm Pract; 2024 Feb; 32(1):46-51. PubMed ID: 37936510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial.
    Krass I; Twigg MJ; Mitchell B; Wilson F; Mohebbi M; Trinder P; Shih STF; Carter R; Versace VL; McNamara K
    BMC Health Serv Res; 2023 Dec; 23(1):1337. PubMed ID: 38041094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance of recommendations by inpatient pharmacy case managers: unintended consequences of hospitalist and specialist care.
    Anderegg SV; Demik DE; Carter BL; Dawson JD; Farris K; Shelsky C; Kaboli P
    Pharmacotherapy; 2013 Jan; 33(1):11-21. PubMed ID: 23307540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a non-physician screening program for hypertension and cardiovascular risk in community pharmacies.
    Pappaccogli M; Ravetto Enri L; Perlo E; Di Monaco S; Pignata I; Baratta F; Rabbia F; Mana M; Veglio F; Brusa P
    Nutr Metab Cardiovasc Dis; 2019 Dec; 29(12):1316-1322. PubMed ID: 31383504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An electronic tool to aid community pharmacists in optimizing care for persons with diabetes.
    Williams SP; Nunemacher C; Holland C; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S136-S140.e4. PubMed ID: 31248846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumers' expectations and experiences with chain community pharmacies in Lahore, Pakistan: a qualitative exploratory study.
    Asif U; Saleem A; Masood I; Nawaz M
    Int J Clin Pharm; 2019 Jun; 41(3):813-819. PubMed ID: 31028597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
    Goode JV; Swiger K; Bluml BM
    J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study.
    Watkins K; Trevenen M; Murray K; Kendall PA; Schneider CR; Clifford R
    BMJ Open; 2016 Aug; 6(8):e012369. PubMed ID: 27580836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensing practice in the community pharmacies in the Turkish Republic of Northern Cyprus.
    Gokcekus L; Toklu HZ; Demirdamar R; Gumusel B
    Int J Clin Pharm; 2012 Apr; 34(2):312-24. PubMed ID: 22262499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engaging community pharmacists in the primary prevention of cardiovascular disease: protocol for the Pharmacist Assessment of Adherence, Risk and Treatment in Cardiovascular Disease (PAART CVD) pilot study.
    Mc Namara KP; George J; O'Reilly SL; Jackson SL; Peterson GM; Howarth H; Bailey MJ; Duncan G; Trinder P; Morabito E; Finch J; Bunker S; Janus E; Emery J; Dunbar JA
    BMC Health Serv Res; 2010 Sep; 10():264. PubMed ID: 20819236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.